Targeting ocular tissues with intravenously administered aptamers selected by in vivo SELEX
Ocular diseases create a significant economic burden and decrease in quality of life worldwide. Drugs and carrier molecules that penetrate ocular tissues after intravenous administration are needed for more efficient and patient-friendly treatment of ocular diseases. Here, ocular barrier-penetrating...
Saved in:
| Main Authors: | Sonja Korhonen, Katja Stenberg, Umair Seemab, Piia Bartos, Katariina Mäkiniemi, Jørgen Kjems, Daniel Miotto Dupont, Astrid Subrizi |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2024-12-01
|
| Series: | Molecular Therapy: Nucleic Acids |
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2162253124002397 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Advantages, applications, and future directions of in vivo aptamer SELEX: A review
by: Minchuan Lyu, et al.
Published: (2025-09-01) -
Advancements in SELEX Technology for Aptamers and Emerging Applications in Therapeutics and Drug Delivery
by: Liangjie Feng, et al.
Published: (2025-06-01) -
A novel hybrid approach to overcome defects of CE-SELEX and cell-SELEX in developing aptamers against aspartate β-hydroxylase
by: Hadi Bakhtiari, et al.
Published: (2025-01-01) -
Specific Aspects of SELEX Protocol: Different Approaches for ssDNA Generation
by: Alexandr Garanin, et al.
Published: (2025-04-01) -
The Power of Old Hats: Rediscovering Inosine-EpPCR to Create Starting Libraries for Whole-Cell-SELEX
by: Grigory Bolotnikov, et al.
Published: (2025-07-01)